Back to results
US 11,780,886 B2Granted
Modified viral vectors and methods of making and using the same
AssigneeuniQure IP B.V.
InventorDavid Johannes Francois Du Plessis
Life of this patent
Estimating the term…
Abstract
The present invention relates to production of parvoviral vectors to produce adeno-associated virus (AAV) for gene therapy. In particular the invention relates to improvements in parvoviral vectors that increase the packaging capacity, production efficiency, and infectivity of AAV virions that is necessary for large scale manufacturing of AAV for clinical purposes.
Claims12
An insect cell expressing adeno-associated virus (AAV) VP1 protein and AAV VP3 protein and not expressing AAV VP2 protein, wherein the insect cell comprises an exogenous nucleotide sequence of 6.1 kb of at least one gene of interest.
Dependencies are inferred from the claim text.